PharmaCyte Biotech, Inc. Share Price
NASDAQ: PMCB | Micro CapPharmaCyte Biotech, Inc. Stock Performance
Open $0.59 | Prev. Close $0.58 | Circuit Range N/A |
Day Range $0.59 - $0.59 | Year Range $0.57 - $1.50 | Volume 309 |
Average Traded $0.59 |
PharmaCyte Biotech, Inc. Share Price Today
As of 9 August 2026, PharmaCyte Biotech, Inc.'s share price is $0.59. The stock opened at $0.59, compared to its previous close of $0.58. During today's trading session, PharmaCyte Biotech, Inc.'s share price traded between $0.59 and $0.59, with an average price of $0.59. Over the past 52 weeks, the stock has recorded a high of $1.50 and a low of $0.57. In terms of performance, PharmaCyte Biotech, Inc.'s share price has declined by 17.31% over the last six months and is down 40.17% on a year-on-year basis.
PharmaCyte Biotech, Inc. Share Price Chart
PharmaCyte Biotech, Inc. Stock Fundamentals & Key Indicators
Market Cap $4.30M | PE Ratio (TTM) 0.18 | Dividend Yield N/A |
EPS (TTM) $3.19 | Revenue (TTM) N/A | Return On Equity (TTM) 59.08% |
Profit Margin N/A | Debt to Equity 0.06 | Quarterly Earnings Growth YoY 48.90% |
PharmaCyte Biotech, Inc. Quarterly Profit & Loss
All figures in USD
PharmaCyte Biotech, Inc. Annual Profit & Loss
All figures in USD
About PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. The company develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; and license agreements with SG Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
PharmaCyte Biotech, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.57 | $0.59 | +2.81% |
Jul 2026 | $0.76 | $0.57 | -25.97% |
Jun 2026 | $0.81 | $0.77 | -5.87% |
May 2026 | $0.74 | $0.82 | +7.77% |
Apr 2026 | $0.71 | $0.76 | +15.00% |
Mar 2026 | $0.70 | $0.66 | -6.91% |
Feb 2026 | $0.80 | $0.71 | -12.68% |
Jan 2026 | $0.70 | $0.81 | +13.88% |
Dec 2025 | $0.75 | $0.71 | -7.40% |
Nov 2025 | $0.93 | $0.77 | -17.20% |
Oct 2025 | $0.96 | $0.93 | -1.17% |
Sep 2025 | $0.95 | $0.94 | -3.98% |
PMCB Share Price FAQs
What is PharmaCyte Biotech, Inc. share price today?
What is the 52 week high and 52 week low of PharmaCyte Biotech, Inc. stock?
What is PMCB's market capitalisation today?
What is PMCB's net income for the last quarter?
What is the 5 year returns of PMCB?
What is the high & low stock price of PMCB today?
Can I buy PMCB shares in India?